Zacks.com on MSN13d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine MenveoGSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
GlobalData on MSN13d
EC approves GSK’s Menveo vaccine presentation for IMDThe European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
GSK plc (LSE/NYSE: GSK) today announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (Meningococcal Group A, C, W-135 and Y conjugate vaccine ...
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...
European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback